Article: New Study Shows Chromium Picolinate and Biotin Combination Significantly Lowers Coronary Risk Factors in People with Type 2 Diabetes.

Results from Diachrome(TM) Clinical Trial Presented at American Heart Association (AHA) ATVB Conference

(Nutrition 21, Inc. Nasdaq: NXXI) -- Results of a new double-blind, placebo-controlled, randomized clinical study show that daily nutritional supplementation with a combination of chromium picolinate and biotin (marketed as Diachrome(TM)) significantly improved coronary risk factors in people with type 2 diabetes. The clinical study, which evaluated 24 patients over 30 days, was presented today at the AHA's Annual Conference on Arteriosclerosis, Thrombosis & Vascular Biology (ATVB) in San Francisco.

The study found the following significant improvements in subjects ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!